Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2009 1
2010 4
2011 4
2012 6
2013 4
2014 2
2015 3
2016 2
2017 2
2018 3
2019 3
2020 5
2021 7
2022 3
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.
de Jong FC, Laajala TD, Hoedemaeker RF, Jordan KR, van der Made ACJ, Boevé ER, van der Schoot DKE, Nieuwkamer B, Janssen EAM, Mahmoudi T, Boormans JL, Theodorescu D, Costello JC, Zuiverloon TCM. de Jong FC, et al. Among authors: zuiverloon tcm. Sci Transl Med. 2023 May 24;15(697):eabn4118. doi: 10.1126/scitranslmed.abn4118. Epub 2023 May 24. Sci Transl Med. 2023. PMID: 37224225 Free PMC article.
Open versus minimal invasive radical cystectomy.
van Diepen DC, Zuiverloon TCM, Klaver SO, Boormans JL. van Diepen DC, et al. Among authors: zuiverloon tcm. Transl Androl Urol. 2020 Dec;9(6):2471-2473. doi: 10.21037/tau-20-878. Transl Androl Urol. 2020. PMID: 33457218 Free PMC article. No abstract available.
Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer.
de Jong FC, Rutten VC, Zuiverloon TCM, Theodorescu D. de Jong FC, et al. Among authors: zuiverloon tcm. Int J Mol Sci. 2021 Mar 10;22(6):2800. doi: 10.3390/ijms22062800. Int J Mol Sci. 2021. PMID: 33802033 Free PMC article. Review.
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
Scholtes MP, Alberts AR, Iflé IG, Verhagen PCMS, van der Veldt AAM, Zuiverloon TCM. Scholtes MP, et al. Among authors: zuiverloon tcm. Int J Mol Sci. 2021 Mar 11;22(6):2832. doi: 10.3390/ijms22062832. Int J Mol Sci. 2021. PMID: 33799514 Free PMC article. Review.
RNA-based urinary assays for non-muscle invasive bladder cancer.
Pijpers OM, de Jong JJ, Zuiverloon TCM, Boormans JL. Pijpers OM, et al. Among authors: zuiverloon tcm. Curr Opin Urol. 2022 Sep 1;32(5):523-530. doi: 10.1097/MOU.0000000000001018. Curr Opin Urol. 2022. PMID: 35916010 Review.
PD-L1 Antibody Comparison in Urothelial Carcinoma.
Rijnders M, van der Veldt AAM, Zuiverloon TCM, Grünberg K, Thunnissen E, de Wit R, van Leenders GJLH. Rijnders M, et al. Among authors: zuiverloon tcm. Eur Urol. 2019 Mar;75(3):538-540. doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27. Eur Urol. 2019. PMID: 30497882 No abstract available.
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III.
Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TCM, Strandgaard T, Kamat AM, Williams SB, Seiler R, Todenhöfer T, Dyrskjøt L, Nawroth R, Goebell P, Schmitz-Dräger B, Sfakianos JP, Meeks J, Horowitz A, Black PC. Reike MJ, et al. Among authors: zuiverloon tcm. Urol Oncol. 2023 May;41(5):211-218. doi: 10.1016/j.urolonc.2022.09.012. Epub 2022 Oct 18. Urol Oncol. 2023. PMID: 36266219 Review.
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.
van Puffelen JH, Novakovic B, van Emst L, Kooper D, Zuiverloon TCM, Oldenhof UTH, Witjes JA, Galesloot TE, Vrieling A, Aben KKH, Kiemeney LALM, Oosterwijk E, Netea MG, Boormans JL, van der Heijden AG, Joosten LAB, Vermeulen SH. van Puffelen JH, et al. Among authors: zuiverloon tcm. J Immunother Cancer. 2023 Jan;11(1):e005518. doi: 10.1136/jitc-2022-005518. J Immunother Cancer. 2023. PMID: 36693678 Free PMC article.
47 results